Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial.
Diabetes Res Clin Pract. 2023 Feb;196:110238. doi: 10.1016/j.diabres.2023.110238. Epub 2023 Jan 5.
Diabetes Res Clin Pract. 2023.
PMID: 36610544
Clinical Trial.
Corrigendum to "Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial" [Diabetes Res. Clin. Pract. 196 (2023) 110238].
Ruiz-de-Adana MS, Domínguez ME, Morillas V, Colomo N, Vallejo-Mora R, Guerrero M, García-Escobar E, Carreira M, Romero-Zerbo Y, Linares F, González-Mariscal I, Bermúdez-Silva FJ, Olveira G, Rojo-Martínez G.
Ruiz-de-Adana MS, et al. Among authors: vallejo mora r.
Diabetes Res Clin Pract. 2024 Apr;210:111620. doi: 10.1016/j.diabres.2024.111620. Epub 2024 Mar 21.
Diabetes Res Clin Pract. 2024.
PMID: 38514300
No abstract available.
Item in Clipboard
Cite
Cite